Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoma, B-Cell, Marginal Zone × Brentuximab Vedotin × Clear all

Sponsor

Conditions

Hodgkin Disease 24 Lymphoma 14 Lymphoma, Large-Cell, Anaplastic 12 Hematologic Diseases 10 Recurrence 8 Lymphoma, T-Cell 7 Lymphoma, Non-Hodgkin 7 Lymphoma, T-Cell, Peripheral 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, B-Cell 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphatic Diseases 3 Leukemia 3 Neoplasms, Germ Cell and Embryonal 2 Neoplasms by Histologic Type 2 Neoplasms 2 Mycosis Fungoides 2 Lymphoproliferative Disorders 2 Lymphoma, T-Cell, Cutaneous 2 Leukemia, Myeloid, Acute 2 Immunoproliferative Disorders 2 Immunoblastic Lymphadenopathy 2 Immune System Diseases 2 Enteropathy-Associated T-Cell Lymphoma 2 Testicular Neoplasms 1 Sezary Syndrome 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Nonseminomatous germ cell tumor 1 Myelodysplastic Syndromes 1 Mastocytosis, Systemic 1

Interventions

Rituximab 59 Cyclophosphamide 47 fludarabine phosphate 37 Whole-Body Irradiation 32 Mycophenolic Acid 29 Peripheral Blood Stem Cell Transplantation 22 Tacrolimus 21 Cyclosporine 20 Busulfan 20 Antilymphocyte Serum 19 Filgrastim 16 Melphalan 14 Methotrexate 13 Etoposide 13 Lenalidomide 11 Cord Blood Stem Cell Transplantation 11 Radiotherapy 10 Granulocyte Colony-Stimulating Factor 10 fludarabine 9 Dexamethasone 9 Sirolimus 8 Prednisone 8 Bortezomib 8 thymoglobulin 7 Flow Cytometry 7 Calcium Dobesilate 7 Cyclosporins 6 Bendamustine Hydrochloride 6 idelalisib 5 ibritumomab tiuxetan 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡